CNBC: Aadil Zaman analyzes Pharma & Tech opportunities in market decline Aadil's Blog Videos In The News Syed Nishat / September 30 <span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span> Aadil Zaman, Partner at Wall Street Alliance Group, appeared on CNBC with Scott Wapner to discuss stocks on our watchlist: Microsoft, Alphabet and Pfizer in this market decline. Disclosure: Personally own MSFT & Alphabet. Sign up for updates & important news Email PhoneThis field is for validation purposes and should be left unchanged. You might also like Syed Nishat / July 20, 2022 CNBC: Aadil Zaman discusses opportunities in Financials & Cloud Technology Aadil Zaman / December 13, 2022 CNBC: Aadil Zaman discusses opportunities & vulnerabilities in the market ;
